NTCOC
MDCO

Northern Trust Company of Connecticut’s Medicines Co MDCO Stock Holding History

Northern Trust Company of Connecticut’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$953K Sell
24,680
-2,100
-8% -$75.1K 0.01% 1366
2013
Q3 		$898K Sell
26,780
-1,870
-7% -$59.6K 0.01% 1378
2013
Q2 		$881K Buy
+28,650
New +$959K 0.01% 1336

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAC
Smith Affiliated Capital New York $86.5B AUM 5.91% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Northern Trust Company of Connecticut's MDCO Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its Medicines Co (MDCO) stake by 7.8% in Q4 2013, selling an estimated $75.1K and leaving 24,680 shares worth $953K. The position accounts for 0.01% of the portfolio, ranked #1366.

Northern Trust Company of Connecticut first reported a position in MDCO in Q2 2013 and has held it in 3 quarters since. 182 funds tracked by Wall St. Rank hold MDCO as of Q4 2013.

  • Northern Trust Company of Connecticut held 24,680 shares of Medicines Co worth $953K as of Q4 2013.
  • Northern Trust Company of Connecticut sold 2,100 Medicines Co shares in Q4 2013, an estimated $75.1K.
  • Medicines Co made up 0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1366 holding.
  • Northern Trust Company of Connecticut first reported a position in Medicines Co in Q2 2013 and has held it in 3 quarters since.
  • 182 funds tracked by Wall St. Rank held Medicines Co as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.